Device: kera-x (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
168 | Ehlers-Danlos syndrome | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01307527 (ClinicalTrials.gov) | November 2008 | 1/3/2011 | Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI | Brittle Cornea Syndrome;Ehlers-Danlos Syndrome Type 6 | Drug: Riboflavin;Device: Kera-X | Hadassah Medical Organization | NULL | Enrolling by invitation | 18 Years | N/A | Both | 1 | N/A | Israel |